Transformer monitoring & diagnostic system (TMDS) market was valued at $2.1 billion in 2025 and is projected to reach $3.8 billion by 2035, growing at a CAGR of 6.3% during the forecast Period (2026-2035). Enhanced gas analysis in transformer health monitoring improves detection of air leaks and insulation degradation, boosting the adoption of TMDS by utilities and industrial operators for real-time insights into transformer conditions and driving market growth. For instance, in April?2025, Vaisala introduced an updated version of its Optimus OPT100 dissolved gas analysis (DGA) monitor with added oxygen and nitrogen measurement parameters. This enhancement improves early detection of air leaks and insulation degradation in power transformers, helping reduce unplanned outages and extend asset life.

China medical simulation market was valued at $161.8 million in 2025 and is projected to reach $762.4 million by 2035, registering a CAGR of 16.8% during the forecast period from 2026 to 2035. The market is advancing as simulation-based education becomes an essential component of clinical training across hospitals and academic institutions. Medical universities and healthcare training centers are increasingly adopting manikin-based simulators, virtual reality platforms, and performance-tracking software to improve procedural competency and patient safety. These technologies allow repeated practice of complex clinical scenarios in controlled environments without exposing patients to risk. As China continues to modernize medical education and expand standardized training programs for physicians and nurses,

China DNA vaccine market was valued at $62.2 million in 2025 and is projected to reach $93.7 million by 2035, expanding at a CAGR of 4.3% during the forecast period from 2026 to 2035. Regulatory clarity and sustained policy support from Chinese authorities are emerging as a key driver for the China DNA vaccine market. The National Medical Products Administration (NMPA) has been progressively strengthening its drug and biologics regulatory framework, which supports innovation while ensuring high safety and quality standards, giving developers a clearer pathway for clinical development and eventual approval. Recent government focus on vaccine R&D and immunization infrastructure aligns with broader public health objectives, encouraging domestic firms to advance nucleic acid-based vaccines, including DNA platforms, through to later-stage clinical evaluation.

Canada DNA vaccine market was valued at $40.99 million in 2025 and is projected to reach $57.65 million by 2035, registering a CAGR of 3.5% during the forecast period from 2026 to 2035. The market is being shaped by notable clinical activity and expanding trial infrastructure, which together are elevating the market’s visibility and potential. A central catalyst is the Phase 1/2 clinical programme for Covigenix VAX-002, a plasmid DNA booster vaccine targeting circulating SARS-CoV-2 variants, which received Health Canada approval to initiate human studies in 2024. 

Asia-Pacific medical simulation market was valued at $373.3 million in 2025 and is projected to reach $1,743.5 million by 2035, registering a CAGR of 16.7% during the forecast period from 2026 to 2035. Across the Asia-Pacific, public health workforce strengthening initiatives in 2025 and 2026 are directly supporting increased adoption of medical simulation products, software, and training services. Policymakers and health authorities are prioritizing competency-based education, structured clinical learning, and continuing professional development to build resilient and quality healthcare systems. This trend is reflected in regional collaborations and programs aimed at digital and lifelong training for health workers, which position simulation as a scalable and outcome-focused solution.

Asia-Pacific DNA vaccine market was valued at $144.6 million in 2025 and is projected to reach $213.4 million by 2035, expanding at a CAGR of 4.1% during the forecast period from 2026 to 2035. The Asia-Pacific DNA vaccine market is expanding in response to the sustained burden of infectious diseases and the need for rapid, adaptable vaccine technologies. DNA vaccines, particularly plasmid-based platforms, are gaining policy and research attention due to their design flexibility, thermal stability profile, and scalable manufacturing potential. Regional governments are strengthening domestic vaccine capabilities as part of pandemic preparedness and biosecurity frameworks. 

Smart projector sales market was valued at $1.6 billion in 2025 and is projected to reach $4.9 billion by 2035, growing at a CAGR of 12.0% during the forecast Period (2026-2035). Digital Light Processing (DLP) technology plays a key role in the smart projector market by enabling high-resolution, high-brightness, and color-accurate projections. Its compact design and reliability support both home and commercial applications, allowing projectors to deliver cinematic visuals on large screens. DLP systems also facilitate features like HDR support, low latency for gaming, and long-lasting laser light sources, enhancing user experience. As consumers seek versatile and immersive display solutions, DLP continues to drive adoption and growth in global smart projector sales.

Roller shutter door market was valued at $6.4 billion in 2025 and is projected to reach $12.1 billion by 2035, growing at a CAGR of 6.7% during the forecast Period (2026-2035). The global demand for residential roller shutter solutions is being driven by homeowners’ preference for durable, secure, and aesthetically appealing entry systems. Manufacturers and suppliers are increasingly focusing on expanding their aluminium-based product portfolios to meet this growing need and to enhance operational capabilities.

Power quality equipment market was valued at $34.8 billion in 2025 and is projected to reach $71.2 billion by 2035, growing at a CAGR of 7.5% during the forecast Period (2026-2035). Strategic investments in manufacturing and production capabilities play a pivotal role in strengthening the global power quality equipment market. By expanding production infrastructure, companies can enhance the availability of critical solutions that ensure stable and reliable electricity across industrial, commercial, and data center applications. Investments in manufacturing and production capacity are crucial for quickly deploying voltage regulators, UPS systems, and harmonic filters in line with market growth trends. For instance, in February 2025, Eaton unveiled plans for a $340?million investment in a new three?phase transformer manufacturing facility in South Carolina, aimed at supporting power quality infrastructure and data center demand.

Peripheral IV catheters market was valued at $5.8 billion in 2025 and is projected to reach $9.9 billion by 2035, growing at a CAGR of 5.6% during the forecast Period (2026-2035). Recent regulatory approvals for advanced dual?lumen and extended?length catheters have enhanced peripheral venous access, allowing clinicians to administer multiple therapies concurrently. This advancement facilitates a wider array of fluid management and intravenous treatments, thereby promoting market growth in hospitals and outpatient facilities. Such regulatory support underscores the increasing adoption of innovative catheter technologies in clinical practice.